Literature DB >> 22542290

Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis.

Fernando C Fervenza1, Richard J H Smith, Sanjeev Sethi.   

Abstract

Severe crescentic and necrotizing glomerulonephritis typically is associated with anti-glomerular basement membrane or antineutrophil cytoplasmic antibodies. In this report, we describe a 23-year-old man with severe crescentic and necrotizing glomerulonephritis. Both anti-glomerular basement membrane and antineutrophil cytoplasmic antibody titers were negative. Kidney biopsy showed bright C3 staining in the mesangium and along capillary walls and no staining for immunoglobulins. Electron microscopy showed waxy deposits (many mesangial; few intramembranous or subendothelial), prompting evaluation of the alternative pathway of complement. Alternative pathway evaluation showed a novel mutation in short consensus repeat (SCR) 19 of complement factor H. In addition, the patient carried complement factor H and C3 risk alleles. Prompt treatment with intravenous steroids followed by oral steroids resulted in symptom alleviation and improved kidney function. This case shows what is to our knowledge a unique and previously unpublished cause of severe crescentic and necrotizing glomerulonephritis. Furthermore, the case demonstrates an expanding spectrum of complement-mediated glomerulonephritis and shows that crescentic and necrotizing glomerulonephritis with solely complement deposits should be evaluated for abnormalities in the alternative pathway of complement.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542290      PMCID: PMC4428583          DOI: 10.1053/j.ajkd.2012.03.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  16 in total

1.  Each of the three binding sites on complement factor H interacts with a distinct site on C3b.

Authors:  T S Jokiranta; J Hellwage; V Koistinen; P F Zipfel; S Meri
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

2.  Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.

Authors:  Valérie Leroy; Véronique Fremeaux-Bacchi; Michel Peuchmaur; Véronique Baudouin; Georges Deschênes; Marie-Alice Macher; Chantal Loirat
Journal:  Pediatr Nephrol       Date:  2010-12-25       Impact factor: 3.714

3.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Authors:  M A Abrera-Abeleda; C Nishimura; J L H Smith; S Sethi; J L McRae; B F Murphy; G Silvestri; C Skerka; M Józsi; P F Zipfel; G S Hageman; R J H Smith
Journal:  J Med Genet       Date:  2005-11-18       Impact factor: 6.318

4.  Allelic variants of complement genes associated with dense deposit disease.

Authors:  Maria Asuncion Abrera-Abeleda; Carla Nishimura; Kathy Frees; Michael Jones; Tara Maga; Louis M Katz; Yuzhou Zhang; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

5.  Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Authors:  Aude Servais; Véronique Frémeaux-Bacchi; Moglie Lequintrec; Rémi Salomon; Jacques Blouin; Bertrand Knebelmann; Jean-Pierre Grünfeld; Philippe Lesavre; Laure-Hélène Noël; Fadi Fakhouri
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

6.  Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Samih H Nasr; Nelson Leung; Julie Vrana; Carl Cramer; Carla M Nester; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 8.237

Review 7.  Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion.

Authors:  Sanjeev Sethi; Carla M Nester; Richard J H Smith
Journal:  Kidney Int       Date:  2011-12-07       Impact factor: 10.612

8.  Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.

Authors:  Rubén Martínez-Barricarte; Meike Heurich; Francisco Valdes-Cañedo; Eduardo Vazquez-Martul; Eva Torreira; Tamara Montes; Agustín Tortajada; Sheila Pinto; Margarita Lopez-Trascasa; B Paul Morgan; Oscar Llorca; Claire L Harris; Santiago Rodríguez de Córdoba
Journal:  J Clin Invest       Date:  2010-09-13       Impact factor: 14.808

9.  Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.

Authors:  T Sakari Jokiranta; Veli-Pekka Jaakola; Markus J Lehtinen; Maria Pärepalo; Seppo Meri; Adrian Goldman
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

10.  Causes of alternative pathway dysregulation in dense deposit disease.

Authors:  Yuzhou Zhang; Nicole C Meyer; Kai Wang; Carla Nishimura; Kathy Frees; Michael Jones; Louis M Katz; Sanjeev Sethi; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

View more
  12 in total

Review 1.  Dense Deposit Disease Mimicking a Renal Small Vessel Vasculitis.

Authors:  Lavleen Singh; Geetika Singh; Swati Bhardwaj; Aditi Sinha; Arvind Bagga; Amit Dinda
Journal:  J Am Soc Nephrol       Date:  2015-09-11       Impact factor: 10.121

2.  Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2012-05-16       Impact factor: 8.860

Review 3.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

Review 4.  Crescentic acute glomerulonephritis with isolated C3 deposition: a case report and review of literature.

Authors:  Song Mao; Xiaoyan Xuan; Yugen Sha; Sanlong Zhao; Aihua Zhang; Songming Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  C3 glomerulonephritis with a severe crescentic phenotype.

Authors:  Aishwarya Ravindran; Fernando C Fervenza; Richard J H Smith; Sanjeev Sethi
Journal:  Pediatr Nephrol       Date:  2017-06-07       Impact factor: 3.714

Review 6.  Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.

Authors:  An S De Vriese; Sanjeev Sethi; Jens Van Praet; Karl A Nath; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 10.121

7.  Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.

Authors:  Cristina Rabasco; Teresa Cavero; Elena Román; Jorge Rojas-Rivera; Teresa Olea; Mario Espinosa; Virginia Cabello; Gema Fernández-Juarez; Fayna González; Ana Ávila; José María Baltar; Montserrat Díaz; Raquel Alegre; Sandra Elías; Monserrat Antón; Miguel Angel Frutos; Alfonso Pobes; Miguel Blasco; Francisco Martín; Carmen Bernis; Manuel Macías; Sergio Barroso; Alberto de Lorenzo; Gema Ariceta; Manuel López-Mendoza; Begoña Rivas; Katia López-Revuelta; José María Campistol; Santiago Mendizábal; Santiago Rodríguez de Córdoba; Manuel Praga
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

8.  Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis.

Authors:  Su-Fang Chen; Feng-Mei Wang; Zhi-Ying Li; Feng Yu; Ming-Hui Zhao; Min Chen
Journal:  Arthritis Res Ther       Date:  2015-05-21       Impact factor: 5.156

9.  Successful management of a patient with a C3 Glomerulonephritis and crescentic pattern: a case report.

Authors:  Ana Pinho; Graça Ferreira; Conceição Mota
Journal:  BMC Res Notes       Date:  2014-11-07

Review 10.  C3 glomerulopathy.

Authors:  H Terence Cook
Journal:  F1000Res       Date:  2017-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.